C

China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570

Watchlist Manager
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Watchlist
Price: 2.31 HKD 1.32% Market Closed
Market Cap: 11.6B HKD
Have any thoughts about
China Traditional Chinese Medicine Holdings Co Ltd?
Write Note

Income Statement

Earnings Waterfall
China Traditional Chinese Medicine Holdings Co Ltd

Revenue
17.2B CNY
Cost of Revenue
-8.6B CNY
Gross Profit
8.6B CNY
Operating Expenses
-7.6B CNY
Operating Income
941.4m CNY
Other Expenses
-24m CNY
Net Income
917.4m CNY

Income Statement
China Traditional Chinese Medicine Holdings Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2004 Dec-2004 Jun-2005 Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
857
N/A
787
-8%
809
+3%
868
+7%
452
-48%
112
-75%
293
+162%
347
+19%
373
+7%
396
+6%
469
+19%
591
+26%
695
+18%
818
+18%
861
+5%
844
-2%
897
+6%
1 031
+15%
1 057
+2%
1 395
+32%
2 129
+53%
2 650
+25%
2 833
+7%
3 709
+31%
5 487
+48%
6 533
+19%
7 233
+11%
8 338
+15%
9 900
+19%
11 259
+14%
12 735
+13%
14 321
+12%
14 039
-2%
14 806
+5%
16 300
+10%
19 053
+17%
16 815
-12%
14 304
-15%
17 696
+24%
18 122
+2%
17 204
-5%
Gross Profit
Cost of Revenue
(771)
(795)
(838)
(974)
(546)
(68)
(173)
(225)
(251)
(255)
(275)
(306)
(329)
(362)
(380)
(388)
(421)
(468)
(455)
(569)
(836)
(1 007)
(1 093)
(1 509)
(2 309)
(2 745)
(3 109)
(3 686)
(4 488)
(5 065)
(5 285)
(5 745)
(5 634)
(5 680)
(6 188)
(7 224)
(7 037)
(7 106)
(8 691)
(8 847)
(8 627)
Gross Profit
86
N/A
(7)
N/A
(29)
-292%
(107)
-268%
(94)
+12%
43
N/A
119
+176%
122
+2%
122
+0%
142
+16%
195
+38%
284
+46%
366
+29%
456
+25%
480
+5%
456
-5%
476
+5%
564
+18%
601
+7%
826
+37%
1 292
+57%
1 643
+27%
1 740
+6%
2 201
+26%
3 178
+44%
3 788
+19%
4 124
+9%
4 652
+13%
5 412
+16%
6 194
+14%
7 450
+20%
8 576
+15%
8 405
-2%
9 126
+9%
10 112
+11%
11 829
+17%
9 778
-17%
7 198
-26%
9 005
+25%
9 274
+3%
8 578
-8%
Operating Income
Operating Expenses
(62)
(43)
(26)
(7)
(628)
(43)
(108)
(89)
(69)
(94)
(123)
(201)
(285)
(362)
(396)
(373)
(342)
(349)
(382)
(571)
(872)
(1 090)
(1 154)
(1 553)
(2 141)
(2 584)
(2 720)
(2 896)
(3 448)
(4 093)
(5 156)
(6 144)
(6 161)
(6 612)
(7 441)
(9 119)
(7 825)
(6 024)
(7 588)
(7 924)
(7 636)
Selling, General & Administrative
(24)
(24)
(26)
(26)
(14)
(45)
(112)
(92)
(72)
(97)
(129)
(212)
(298)
(372)
(405)
(382)
(328)
(332)
(363)
(554)
(886)
(1 125)
(1 182)
(1 468)
(1 964)
(2 379)
(2 421)
(2 774)
(3 302)
(3 879)
(4 920)
(5 812)
(5 849)
(6 294)
(7 007)
(8 570)
(7 256)
(5 560)
(7 102)
(7 455)
(7 180)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(17)
0
(18)
0
0
0
0
(112)
(100)
(187)
(208)
(202)
(230)
(347)
(406)
(464)
(500)
(550)
(600)
(694)
(717)
(612)
(608)
(686)
(640)
Depreciation & Amortization
(34)
(34)
(17)
0
0
0
0
0
0
0
0
0
0
0
0
0
(5)
0
(5)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Operating Expenses
(4)
15
17
19
(614)
2
4
3
3
3
6
10
12
10
9
9
7
(17)
4
(17)
14
35
29
28
(77)
(19)
(90)
80
83
132
171
131
188
233
166
146
149
148
122
216
184
Operating Income
24
N/A
(50)
N/A
(55)
-10%
(113)
-106%
(722)
-537%
1
N/A
11
+2 080%
33
+204%
53
+60%
48
-10%
72
+50%
83
+16%
81
-3%
94
+17%
85
-10%
83
-2%
134
+61%
215
+61%
220
+2%
255
+16%
420
+65%
553
+32%
586
+6%
648
+11%
1 037
+60%
1 203
+16%
1 404
+17%
1 756
+25%
1 964
+12%
2 100
+7%
2 294
+9%
2 432
+6%
2 244
-8%
2 514
+12%
2 671
+6%
2 710
+1%
1 953
-28%
1 175
-40%
1 417
+21%
1 350
-5%
941
-30%
Pre-Tax Income
Interest Income Expense
(25)
(22)
(21)
(20)
(10)
(7)
(7)
(1)
(1)
(0)
(2)
(3)
(2)
(1)
(4)
(5)
(9)
2
(0)
(16)
(41)
(63)
(31)
42
28
102
35
(188)
(193)
(246)
(247)
(268)
(269)
(214)
(212)
(151)
(130)
(138)
(162)
(108)
(127)
Non-Reccuring Items
0
0
(101)
(731)
0
0
0
0
0
0
0
0
8
8
(0)
(0)
0
(0)
(1)
(1)
(1)
(1)
(0)
(1)
(2)
(2)
(1)
(1)
(0)
3
(53)
(9)
29
(70)
(22)
(21)
(13)
(178)
(177)
12
4
Total Other Income
0
0
0
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
(18)
(18)
(19)
0
(30)
(1)
Pre-Tax Income
(1)
N/A
(72)
-5 057%
(176)
-144%
(864)
-391%
(731)
+15%
(6)
+99%
4
N/A
32
+737%
52
+64%
48
-8%
70
+47%
80
+14%
87
+9%
101
+16%
81
-20%
78
-3%
125
+59%
216
+74%
219
+1%
238
+9%
378
+59%
489
+29%
555
+13%
689
+24%
1 063
+54%
1 304
+23%
1 438
+10%
1 567
+9%
1 771
+13%
1 857
+5%
1 994
+7%
2 155
+8%
2 005
-7%
2 230
+11%
2 438
+9%
2 520
+3%
1 792
-29%
840
-53%
1 077
+28%
1 225
+14%
817
-33%
Net Income
Tax Provision
(7)
8
12
19
13
(1)
0
(8)
(18)
(5)
(7)
(20)
(23)
(26)
(16)
(17)
(30)
(43)
(43)
(38)
(57)
(70)
(81)
(119)
(192)
(217)
(233)
(256)
(288)
(290)
(307)
(381)
(355)
(369)
(401)
(397)
(254)
(119)
(161)
172
176
Income from Continuing Operations
(9)
(64)
(164)
(845)
(718)
(7)
4
24
35
43
63
60
63
75
64
61
95
173
176
199
321
419
474
570
871
1 087
1 204
1 311
1 483
1 567
1 687
1 773
1 649
1 861
2 037
2 123
1 538
721
916
1 396
993
Income to Minority Interest
(6)
5
8
47
118
97
15
(16)
(22)
(25)
(27)
(21)
(25)
(22)
(6)
(1)
(2)
(5)
0
(5)
(5)
(2)
(3)
(24)
(86)
(120)
(129)
(141)
(151)
(128)
(149)
(185)
(188)
(197)
(176)
(191)
(122)
44
13
(111)
(76)
Net Income (Common)
(15)
N/A
(59)
-296%
(156)
-163%
(798)
-412%
(983)
-23%
(349)
+65%
(37)
+89%
8
N/A
13
+59%
18
+40%
37
+103%
39
+5%
39
-1%
53
+38%
58
+10%
60
+3%
93
+55%
168
+82%
168
-1%
199
+19%
325
+64%
413
+27%
459
+11%
626
+36%
882
+41%
967
+10%
1 075
+11%
1 170
+9%
1 332
+14%
1 439
+8%
1 538
+7%
1 588
+3%
1 461
-8%
1 663
+14%
1 861
+12%
1 933
+4%
1 417
-27%
764
-46%
930
+22%
1 285
+38%
917
-29%
EPS (Diluted)
-0.01
N/A
-0.07
-600%
-0.19
-171%
-0.96
-405%
-1.18
-23%
-0.41
+65%
-0.04
+90%
0.01
N/A
0.02
+100%
0.02
N/A
0.03
+50%
0.03
N/A
0.03
N/A
0.04
+33%
0.04
N/A
0.04
N/A
0.06
+50%
0.1
+67%
0.1
N/A
0.1
N/A
0.13
+30%
0.16
+23%
0.17
+6%
0.16
-6%
0.18
+13%
0.22
+22%
0.25
+14%
0.26
+4%
0.29
+12%
0.3
+3%
0.31
+3%
0.32
+3%
0.29
-9%
0.33
+14%
0.37
+12%
0.38
+3%
0.28
-26%
0.15
-46%
0.18
+20%
0.26
+44%
0.18
-31%

See Also

Discover More